Share Facebook Twitter LinkedIn Pinterest Email SpringWorks stock rallies 18% post-market on FDA approval of Ogsiveo
Zscaler forecasts 16%-17% fiscal 2027 ARR and revenue growth while targeting $4.10-$4.11 FY2026 EPS (NASDAQ:ZS)May 27, 2026